Wikidata

(Q43031861)

English

Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: a phase 1b multiple ascending dose study.

scientific article published on 24 February 2011

In more languages

Statements

title
Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: a phase 1b multiple ascending dose study (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21145848
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21145848%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43031861&oldid=1596731092"